| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.23 | 0.1 |